- Home
- Publications
- Publication Search
- Publication Details
Title
NAFLD and diabetes mellitus
Authors
Keywords
-
Journal
Nature Reviews Gastroenterology & Hepatology
Volume 14, Issue 1, Pages 32-42
Publisher
Springer Nature
Online
2016-10-12
DOI
10.1038/nrgastro.2016.147
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis
- (2016) Andrea Marengo et al. Annual Review of Medicine
- Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease
- (2016) Joel T. Haas et al. Annual Review of Physiology
- Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes
- (2016) Romina Lomonaco et al. DIABETES CARE
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) et al. DIABETOLOGIA
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage
- (2016) Benedetta Donati et al. HEPATOLOGY
- Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial
- (2016) Jeffrey Cui et al. JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants
- (2016) LANCET
- The Relationship of Diabetes and Smoking Status to Hepatocellular Carcinoma Mortality
- (2016) Chien-Hsieh Chiang et al. MEDICINE
- Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE
- (2015) I. Doycheva et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Time course of postprandial hepatic phosphorus metabolites in lean, obese, and type 2 diabetes patients
- (2015) Maria Fritsch et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Hepatic Acetyl CoA Links Adipose Tissue Inflammation to Hepatic Insulin Resistance and Type 2 Diabetes
- (2015) Rachel J. Perry et al. CELL
- Adaptation of Hepatic Mitochondrial Function in Humans with Non-Alcoholic Fatty Liver Is Lost in Steatohepatitis
- (2015) Chrysi Koliaki et al. Cell Metabolism
- Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes
- (2015) Aijaz Ahmed et al. Clinical Gastroenterology and Hepatology
- Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
- (2015) Jessica Bazick et al. DIABETES CARE
- Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome
- (2015) Amedeo Lonardo et al. DIGESTIVE AND LIVER DISEASE
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
- (2015) Guillaume Lassailly et al. GASTROENTEROLOGY
- Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study
- (2015) Raymond Kwok et al. GUT
- Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study
- (2015) Edith M. Koehler et al. HEPATOLOGY
- Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta-analysis
- (2015) Siddharth Singh et al. HEPATOLOGY
- High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
- (2015) Paola Portillo-Sanchez et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver
- (2015) Santhosh Satapati et al. JOURNAL OF CLINICAL INVESTIGATION
- Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2
- (2015) You Zhou et al. JOURNAL OF HEPATOLOGY
- Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
- (2015) Stuart McPherson et al. JOURNAL OF HEPATOLOGY
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Current efforts and trends in the treatment of NASH
- (2015) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats
- (2015) R. J. Perry et al. SCIENCE
- Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo
- (2015) Paul M. Titchenell et al. Nature Communications
- Roux-en-Y Gastric Bypass Versus Adjustable Gastric Banding to Reduce Nonalcoholic Fatty Liver Disease
- (2014) Robert Caiazzo et al. ANNALS OF SURGERY
- Increased cancer incidence risk in type 2 diabetes mellitus: results from a cohort study in Tyrol/Austria
- (2014) Willi Oberaigner et al. BMC PUBLIC HEALTH
- GFT505 for the treatment of nonalcoholic steatohepatitis and type 2 diabetes
- (2014) Bertrand Cariou et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Pathological Features of Fatty Liver Disease
- (2014) Matthew M. Yeh et al. GASTROENTEROLOGY
- Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer
- (2014) Krasimira Aleksandrova et al. HEPATOLOGY
- Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
- (2014) Julia Kozlitina et al. NATURE GENETICS
- Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
- (2014) Gerald I. Shulman NEW ENGLAND JOURNAL OF MEDICINE
- Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans
- (2014) Julia Szendroedi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors
- (2014) Rebecca A. Haeusler et al. Nature Communications
- Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial
- (2014) Norbert Stefan et al. Lancet Diabetes & Endocrinology
- Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
- (2014) Hannele Yki-Järvinen Lancet Diabetes & Endocrinology
- Population-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States
- (2013) Tania M Welzel et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Inflammation, Cytokines and Insulin Resistance: A Clinical Perspective
- (2013) Verena Wieser et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- The Origins and Drivers of Insulin Resistance
- (2013) Andrew M.F. Johnson et al. CELL
- Immunological Goings-on in Visceral Adipose Tissue
- (2013) Diane Mathis Cell Metabolism
- Adipocyte Lipid Chaperone aP2 Is a Secreted Adipokine Regulating Hepatic Glucose Production
- (2013) Haiming Cao et al. Cell Metabolism
- Lower Fasting Muscle Mitochondrial Activity Relates to Hepatic Steatosis in Humans
- (2013) J. Szendroedi et al. DIABETES CARE
- Effects of pioglitazone versus glimepiride exposure on hepatocellular fat content in type 2 diabetes
- (2013) E. Phielix et al. DIABETES OBESITY & METABOLISM
- Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
- (2013) Jennifer E. Lambert et al. GASTROENTEROLOGY
- Extrahepatic complications of nonalcoholic fatty liver disease
- (2013) Matthew J. Armstrong et al. HEPATOLOGY
- Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
- (2013) Barbara Fruci et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Resolution of Fatty Liver and Risk of Incident Diabetes
- (2013) Ki-Chul Sung et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes
- (2013) Iliana Doycheva et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver
- (2013) Raluca Pais et al. JOURNAL OF HEPATOLOGY
- A population-based study on the prevalence of NASH using scores validated against liver histology
- (2013) Jenni Hyysalo et al. JOURNAL OF HEPATOLOGY
- Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: The Edinburgh type 2 diabetes study
- (2013) Joanne R. Morling et al. JOURNAL OF HEPATOLOGY
- Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team
- (2013) Jessica Dyson et al. JOURNAL OF HEPATOLOGY
- A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity
- (2013) Miki Okada-Iwabu et al. NATURE
- Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus
- (2013) Stefan Kiechl et al. NATURE MEDICINE
- Noninvasive evaluation of NAFLD
- (2013) Laurent Castera et al. Nature Reviews Gastroenterology & Hepatology
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- From NAFLD to NASH to cirrhosis—new insights into disease mechanisms
- (2013) Alexander Wree et al. Nature Reviews Gastroenterology & Hepatology
- Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
- (2013) Monica Franciosi et al. PLoS One
- Diabetes Mellitus Is Associated with Hepatocellular Carcinoma: A Retrospective Case-Control Study in Hepatitis Endemic Area
- (2013) Ze Zheng et al. PLoS One
- Non-alcoholic steatohepatitis: a microbiota-driven disease
- (2013) Alexander R. Moschen et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease
- (2013) Melania Gaggini et al. Nutrients
- Mechanisms for Insulin Resistance: Common Threads and Missing Links
- (2012) Varman T. Samuel et al. CELL
- Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
- (2012) G. Musso et al. DIABETOLOGIA
- Intrahepatic Diacylglycerol Content Is Associated With Hepatic Insulin Resistance in Obese Subjects
- (2012) Faidon Magkos et al. GASTROENTEROLOGY
- Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis
- (2012) Rohit Loomba et al. HEPATOLOGY
- Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1
- (2012) Mingjian Lu et al. NATURE MEDICINE
- Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma
- (2011) Kohichiroh Yasui et al. Clinical Gastroenterology and Hepatology
- Primary human bone marrow adipocytes support TNF-α-induced osteoclast differentiation and function through RANKL expression
- (2011) Hisataka Goto et al. CYTOKINE
- Subcutaneous Adipose Tissue Macrophage Infiltration Is Associated With Hepatic and Visceral Fat Deposition, Hyperinsulinemia, and Stimulation of NF-κB Stress Pathway
- (2011) Kim-Anne Lê et al. DIABETES
- Liver ATP Synthesis Is Lower and Relates to Insulin Sensitivity in Patients With Type 2 Diabetes
- (2011) A. I. Schmid et al. DIABETES CARE
- Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance
- (2011) Hui-Young Lee et al. HEPATOLOGY
- Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: A 12-month randomized, prospective, open- label trial
- (2011) Dawn M. Torres et al. HEPATOLOGY
- Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
- (2011) Romina Lomonaco et al. HEPATOLOGY
- Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents
- (2011) Joel E. Lavine JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Unknown
- (2011) Alexander Moschen et al. MOLECULAR MEDICINE
- Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease
- (2011) N. Kumashiro et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of metformin and thiazolidinediones in the regulation of hepatic glucose metabolism and its clinical impact
- (2011) Esther Phielix et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Nonalcoholic Fatty Liver Disease Increases Risk of Death Among Patients With Diabetes: A Community-Based Cohort Study
- (2010) Leon A Adams et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Mitochondria and Redox Signaling in Steatohepatitis
- (2010) E. Matthew Morris et al. ANTIOXIDANTS & REDOX SIGNALING
- Dissociation Between Intrahepatic Triglyceride Content and Insulin Resistance in Familial Hypobetalipoproteinemia
- (2010) Anastassia Amaro et al. GASTROENTEROLOGY
- Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
- (2010) Christopher D. Williams et al. GASTROENTEROLOGY
- Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor expression
- (2010) A. R. Moschen et al. GUT
- Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data
- (2010) Nazim Ghouri et al. HEPATOLOGY
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
- Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus
- (2010) Nathalie C. Leite et al. LIVER INTERNATIONAL
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insulin Resistance is the Best Predictor of the Metabolic Syndrome in Subjects With a First-Degree Relative With Type 2 Diabetes
- (2010) Kristina M. Utzschneider et al. Obesity
- Independent Predictors of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2009) Noreen Hossain et al. Clinical Gastroenterology and Hepatology
- Alanine Aminotransferase, -Glutamyltransferase, and Incident Diabetes: The British Women's Heart and Health Study and meta-analysis
- (2009) A. Fraser et al. DIABETES CARE
- Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial
- (2009) Vlad Ratziu et al. HEPATOLOGY
- Abnormal hepatic energy homeostasis in type 2 diabetes
- (2009) Julia Szendroedi et al. HEPATOLOGY
- A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis
- (2009) Shaoqing He et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
- (2009) John Willy Haukeland et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trial
- (2009) William W. Shields et al. Therapeutic Advances in Gastroenterology
- Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
- (2008) Vlad Ratziu et al. GASTROENTEROLOGY
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
- Aminotransferase Levels and 20-Year Risk of Metabolic Syndrome, Diabetes, and Cardiovascular Disease
- (2008) Wolfram Goessling et al. GASTROENTEROLOGY
- Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury
- (2008) G Serviddio et al. GUT
- Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes
- (2008) Anna Ludovica Fracanzani et al. HEPATOLOGY
- Unknown
- (2008) Herbert Tilg et al. MOLECULAR MEDICINE
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
- Mitochondrial adaptations to steatohepatitis induced by a methionine- and choline-deficient diet
- (2007) Caroline Romestaing et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Alterations in Adipose Tissue and Hepatic Lipid Kinetics in Obese Men and Women With Nonalcoholic Fatty Liver Disease
- (2007) Elisa Fabbrini et al. GASTROENTEROLOGY
- Quantitative ATP synthesis in human liver measured by localized31P spectroscopy using the magnetization transfer experiment
- (2007) A. I. Schmid et al. NMR IN BIOMEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now